Fastnet Equity Share Discussion Threads

[pottermagic2310] 04/3/2016 20:45

So we'll see at least another 350,000,000 shares issued to allow Amryt to become a majority shareholder... even though Amyrt is a Shell Company setup by CF.
In that scenario FAST/Amyrt Shares (with a current CAP of £9.8m) would be worth just £0.0125 each ???... and CF becomes THE majority Shareholder again as one of the primary Amyrt Directors and major Shareholders!!

The new Entity is still worth £9.8m (perhaps) but based on Reports elsewhere the purchase price for the 2 real Pharma Companies in Switzerland & Germany might require £20m ??? (Not sure how true that is?)

So at the very least that might mean raising another £10-12m??
Presumably that might mean offering another 1,200,000,000 Shares at maybe 1p per Share ??
In that scenario whatever we have today would be worth 1p/share in the end, about a 65% dilution.
But then there's the Valuation attributed to the 2 Companies acquired, assuming this doesn't just become a Fund Raiser and the acquisitions really do take place ?
All-in-all... it's a write-off unless/until acquisitions are completed and the Pharma's Products become viable and a Market for them is truly realised.

Maybe all is not lost ???

[risk1] 04/3/2016 19:01

To be honest I thought he was taking the P

I do think that his share price prediction is achievable however based on CF paying 4p for his shares and any deal is likely to add value or why bother doing a deal

[papillon] 04/3/2016 18:38

pottermagic2310? More like pottymagic, risk1.

There will be a lot of dilution for existing holders, pottymagi, we just don't know how much at this moment in time. It's an RTO after all plus there is to be a substantial placing (£20m) pre the re-listing which will also substantially increase the number of shares in issue (we don't know how many because we don't yet know the placing price)! However I think your 5.5p target Amyrt share price on re-listing is definitely achievable; it might even be an over cautious target share price

[risk1] 04/3/2016 15:28

Sorry mate you really shouldn't be on the stock market

[pottermagic2310] 04/3/2016 15:03

WOW... so we're effectively completely worthless then and may see 99 of our Shares swapped for perhaps only 1 Share in the new Company... or worse ?!!!

MUGGED !!!

[risk1] 04/3/2016 13:04

Don't think that is possible mate

Fastnet have to give equity to the company reversing in

[pottermagic2310] 04/3/2016 11:23

My post is exactly as written - I believe it might be possible to achieve 5.5p/share as-is, with no further dilution - simple as that and assumes Share trading comes out of suspension and the proposed reverse takeover goes ahead as has been suggested elsewhere.

[risk1] 04/3/2016 09:49

Sorry I don't understand your post

I am assuming over 100 pc dilution but am hopeful that 5.5p per share is achievable

[jacksonpollack] 03/3/2016 18:04

Just for old times sake. Boring zzzzz. When are we coming out of suspension, lol.

[papillon] 03/3/2016 17:17

Fast and Faster - (FAST)
21/12/2015 (119264)

Fast and Faster - (FAST)
21/12/2015 (119264)


Amazing to see a few grouchy bulletin board punters moaning about the detail at Fastnet Equity (FAST). The boys in Dublin tried to build a big winner in the oil and gas game, enjoyed a great run for a while, but ultimately failed. All praise now to Cathal Friel, the investment banker chairman, for saving the shell and trying to make it a winner second time around.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

" Amazing to see a few grouchy bulletin board punters moaning"

I think Michael Walters was writing about you back then JacksonPollack!

[jacksonpollack] 01/3/2016 21:37

Cathal Friel
MD Raglan Capital
Cathal is the founder and Managing Director of Raglan Capital, and has over 30 years of capital markets, corporate finance and entrepreneurial experience. He has an extensive network of contacts across the capital markets both in Europe and N. America and has many years of experience as a successful adviser and entrepreneurial developer of companies across a number of sectors. In recent years he has developed an extensive practice in the life science space, having helped found and develop a number of life science companies. He has both operational experience of establishing, funding and developing life science companies and also being a valued financial advisor to companies, creating shareholder value through fundraising, IPOs and subsequent trade sales.‎

He helped establish and fund two junior oil and gas exploration companies, Fastnet Oil & Gas plc which floated on the London and Dublin stock exchanges in 2011 having raised over $50m and remained as Chairman from IPO to its successful transition from oil and gas to a healthcare investment company. He also helped establish and fund T5 Oil & Gas Limited. Cathal is one of the founders of Amryt Pharmaceuticals, an Irish-domiciled orphan drug company having helped establish and fund the Company prior to a planned IPO early 2016.

Cathal was one of the Founding Directors of Merrion Stockbrokers and helped build it up from scratch in 2000 to one of the four leading stockbrokers in Ireland prior to its successful sale in 2006 for close to €100m and assisted Merrion’s new owners in acquiring two London brokers Teathers & Greenwood and Bridgewell Securities. He was also a former Chairman of the Irish Software Association for two years after having been involved in a number of software companies. He previously held the positions of Chief Investment Officer at Powerscourt Investments and, prior to that, Deputy Chief Executive Officer of Allfinanz Software, which subsequently sold to Munich Re for over €50m.

Cathal has an MBA from University of Ulster. He also lectured on a part times basis in the University of Ulster for five years from 1990 in International Marketing and Strategic Planning while running his own business.

[jacksonpollack] 01/3/2016 21:32

26th and 27th May 2016 cathal friel in one of the main speakers at this pharma conference. I would have thought he would be going there having tied up the fastnet RTO business first. So we could be back in action as early as sometime in May with a massive investment in the bag. Things just go from strength to strength here. Just take a look at the quality of people going to this summit. www.futurehealthsummit.com

[badday] 29/2/2016 19:20

No idea, but it shouldn't be that long. After all, they have target, they have big industry player, and I'm sure it's in interests of all to get things moving.
Mike Walters has made his previous article on FAST free to read. This is from late December

[risk1] 29/2/2016 15:04

Thanks

How long do you think before we will hear anything?

Will it be weeks or months?

[badday] 29/2/2016 14:58

risk1

Probably...


An editied, relevelent section from the Michaelwalters post


(Only Subscribers can read full article)


'There is a road show about to start, trudging around institutions for a couple of weeks with the aim of raising ...... They will be seeking to place new shares at a premium ... Along the way, many of the most popular small company brokers look as if they will be brought in on the act, and though there is unlikely to be a formal offer to private investors, most who want to will probably be able to get in on thee placing. '

[risk1] 29/2/2016 13:58

That would be nice

I would like the opportunity to invest in the placing

Will we get a chance?

[soul limbo] 29/2/2016 13:13

another example is DDDD. Floated back in early 2014 at around a pound. 12 months later hit over £10. They're acquisition at floatation cost them just £500k. No revenue. They have respected management.... similar to what FAST will have.

Market cap now over £500m

[risk1] 28/2/2016 13:09

another Cove let's hope so

But as you correctly point out we have no idea of the value of birken or son or the amount of equity we are giving them

Having said that I hope it 10 bags on day 1 and current shareholders get the opportunity to buy a stake in the new company limiting our dilution

😀😀

[papillon] 28/2/2016 12:58

An 180 degree about turn, JP, but I do agree with you. After reading some of the links posted on this bb this could FLY on re-listing. This could be another COVE, but based on biotech instead of O&G.

[jacksonpollack] 28/2/2016 10:36

Good times ahead here. Have read up just about all I can find on our investment targets and bods and this could be the perfect storm. Harry and cathal have both got the business nouse and are well respected by their peers that should see this as a major success.

[risk1] 27/2/2016 22:08

I would like the opportunity to buy some Amryt shares

Any hope?